Perfil
Sophia Paspal worked as a Director of Regulatory Affairs & Oncology at Halozyme Therapeutics, Inc. from 2015 to 2017.
Prior to that, she was an Associate Director of Regulatory Affairs & Neurology at Dart NeuroScience LLC in 2014-2015.
Dr. Paspal also served as the Chief Development Officer at Xynomic Pharmaceuticals Holdings, Inc. Dr. Paspal received her undergraduate and doctorate degrees from the University of Minnesota.
Antiguos cargos conocidos de Sophia Paspal.
| Empresas | Cargo | Fin |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
Dart NeuroScience LLC
Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory | Corporate Officer/Principal | 01/01/2015 |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Director Técnico/Científico/I+D | - |
Formación de Sophia Paspal.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dart NeuroScience LLC
Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory | Health Technology |
Xynomic Pharmaceuticals Holdings, Inc.
Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs | Health Technology |
- Bolsa de valores
- Insiders
- Sophia Paspal
















